EU Cosmetics Regulation for Toothpaste Tablets: What Every Brand Owner Must Know Before Launching in Europe

Europe is widely recognized as one of the most lucrative—yet strictly regulated—cosmetics markets in the world. For oral care brand owners, the biggest anxiety before entering the EU market is compliance: CPNP registration, restricted ingredients, labeling requirements, and the complex Responsible Person system. In this post, you'll learn the exact step-by-step process to navigate the EU Cosmetics Regulation (EC) No 1223/2009 and successfully launch your toothpaste tablets in Europe.

1. Understanding the EU Regulatory Framework for Oral Care

In the European Union, toothpaste tablets are generally classified as cosmetic products, provided their primary function is to clean, perfume, or protect the teeth and oral cavity. The overarching legal framework governing these products is Regulation (EC) No 1223/2009 [1].

Unlike the FDA's OTC monograph system in the US, the EU does not require pre-market approval for cosmetics. Instead, it relies on a strict pre-market notification system and places the burden of safety entirely on a designated entity known as the Responsible Person.

2. The Role of the EU Responsible Person (RP)

You cannot sell cosmetic products in the EU without an appointed Responsible Person (RP). The RP must be a legal or natural person established within the European Community.

The RP is legally responsible for ensuring your toothpaste tablets comply with all aspects of the regulation, including:

• Ensuring product safety (Article 3)
• Maintaining Good Manufacturing Practices (GMP) (Article 8)
• Keeping the Product Information File (PIF) accessible for 10 years (Article 11)
• Reporting serious undesirable effects (Cosmetovigilance)

For non-EU brands, this usually means hiring a professional regulatory consultancy or relying on an EU-based importer to act as the RP.

3. The 5-Step CPNP Notification Process

Before your toothpaste tablets can cross European borders, they must be registered in the Cosmetic Products Notification Portal (CPNP). This is a centralized, free online notification system managed by the European Commission.

Here is the standard workflow for CPNP registration:

1. Appoint an EU Responsible Person: Establish your legal representative in the EU.
2. Formulation Review: Cross-check all ingredients against Annex II (prohibited substances) and Annex III (restricted substances).
3. Compile the Product Information File (PIF): This dossier includes the Cosmetic Product Safety Report (CPSR), manufacturing methods, and proof of claims.
4. Label Review: Ensure your packaging meets the strict requirements of Article 19.
5. CPNP Notification: The RP submits the product details electronically. Once notified, the product can be sold in all EU member states.

4. Ingredient Restrictions: The 2024 Nano-Hydroxyapatite Update

When formulating toothpaste tablets for the EU, ingredient compliance is your biggest hurdle. The EU bans over 1,300 substances under Annex II of Regulation (EC) No 1223/2009 [1].

A critical update for oral care brands is Regulation (EU) 2024/858, published in March 2024, which introduces strict new rules for nanomaterials [2]. If your formula uses Nano-Hydroxyapatite (nHA), you must adhere to these limits:

• Maximum concentration: 10% in toothpaste and 0.465% in mouthwash.
• Physical properties: Particles must be rod-shaped with a controlled aspect ratio and must not be coated or modified.
• Exposure: The product must not allow inhalation exposure.

Additionally, traditional ingredients face strict limits. Fluoride is restricted to a maximum of 0.15% (1500 ppm), and preservatives like BHT are heavily regulated. Partnering with an experienced OEM toothpaste manufacturer like Qiaoerna ensures your formulas are EU-compliant from day one.

5. Mastering EU Labeling Requirements

A non-compliant label can result in your products being seized at customs. Under Article 19 of the regulation, your toothpaste tablet packaging must clearly display:

• The name and address of the EU Responsible Person.
• The nominal content at the time of packaging (by weight or volume).
• The date of minimum durability (or Period After Opening symbol).
• Particular precautions for use.
• The batch number of manufacture.
• The function of the cosmetic product.
• A complete INCI ingredient list.

Conclusion

Launching toothpaste tablets in the EU requires meticulous planning, from appointing a Responsible Person to compiling a robust PIF and navigating the latest nano-hydroxyapatite restrictions. By understanding the CPNP process and partnering with a compliance-focused manufacturer, brand owners can confidently unlock the lucrative European oral care market.

Ready to launch your EU-compliant toothpaste tablet brand? Contact Qiaoerna today to discuss your formulation, compliance documentation, and private label options.

References

[1] European Parliament and Council. (2009). Regulation (EC) No 1223/2009 on cosmetic products. Official Journal of the European Union. Retrieved from EUR-Lex.

[2] European Commission. (2024). Commission Regulation (EU) 2024/858 amending Regulation (EC) No 1223/2009 as regards the use of the nanomaterials Hydroxyapatite (nano). Official Journal of the European Union. Retrieved from EUR-Lex.

Recommended EU-Compliant Products for Your Brand

If you are looking for a reliable manufacturing partner to help you navigate EU regulations, consider these premium formulations:

• Engineered OEM Toothpaste Tablets – Pharmaceutical-Grade Formula
• Plastic-Free and Sustainable Enamel Repair Toothpaste Tablets
• Prebiotic Toothpaste Tablets for Oral Microbiome Balance
• Hydroxyapatite Printed Animal Character Toothpaste Tablets for Kids